ARWR

41.3705.22%
MM

Mark M. Davis

Founder and Founder & Director of Insert Therapeutics Inc & Calando

Dr. Mark M. Davis, Ph.D. is Senior Scientific Advisor of CancerVax, Inc. Dr. Davis is Member of Scientific Advisory Board of Red Tree Venture Capital. Dr. Davis is Member of Scientific Advisory Council of Cancer Research Institute, Inc. He is Member of Scientific Advisory Board of NewLimit, Inc. Dr. Davis is Member of Scientific Advisory Board of 3T Biosciences, Inc. He was Member of Scientific Advisory Board of Lycia Therapeutics, Inc. until 2026. Dr. Mark M. Davis, Ph.D. is Co-Chairman of Scientific Advisory Board at Chongqing TCRCure Biotechnology Co., Ltd. Dr. Davis serves as Member of Scientific Advisory Board at Janux Therapeutics, Inc. He serves as Member of Scientific Advisory Board at Quadriga BioSciences, Inc. He is the Burt and Marion Avery Family Professor of Immunology, Director of the Institute for Immunity, Transplantation and Infection. He serves as Member of Scientific Advisory Board at PACT Pharma, Inc. He is Scientific Co-Founder & Member of Scientific Advisory Board at Mozart Therapeutics, Inc. Dr. Davis serves as Member of Scientific Advisory Board at IGM Biosciences, Inc. He served as Member of Scientific Advisory Board at A2 Biotherapeutics, Inc. Dr. Davis serves as Chief Scientific Advisor of Calando Pharmaceuticals, Inc. Dr. Davis is the Founder of Insert Therapeutics Inc., a subsidiary of Arrowhead Pharmaceuticals, Inc. (formerly known as Arrowhead Research Corp.) He co-founded Calando Pharmaceuticals, Inc. in 2005 and serves as its Chief Scientific Advisor. He serves as an Advisor of Intellia Therapeutics Inc. Dr. Davis had served as Scientific Advisor at Vir Biotechnology, Inc. until May, 2022. His research focuses on how T cells and B cells recognize specific antigens and behave following such interactions. He has authored more than 350 peer-reviewed articles and books and received numerous awards and honors for his work, including memberships in the National Academy of Sciences, The National Academy of Medicine and the Royal Society. This includes the structural and biochemical underpinnings of T cell receptor binding and signal transduction and the dynamics of molecular movement at the T cell/antigen-presenting cell interface. He discovered the T cell receptor gene, developed peptide-MHC tetramers to study T cell populations capable of recognizing specific targets and elucidated and quantified specific events at the immunologic synapse required for T cell function. Dr. Davis serves as Chairman of the Microbiology & Immunology Department of Stanford Medical School. He serves as Director of Stanford Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine. He served as Chief Executive Officer and President for Calando of Arrowhead Pharmaceuticals, Inc. (formerly known as Arrowhead Research Corp.) until October 2007. Dr. Davis serves as Member of scientific team of Insert Therapeutics, Inc. He serves as a Director of Insert Therapeutics, Inc. He serves as a Director of Calando Pharmaceuticals, Inc. He served as Director of InfoVista SA. He served as Member of Scientific Advisory Board of Cellerant Therapeutics, Inc., Arbor Vita Corporation. He served as a Member of Scientific Advisory Board of Arrowhead Pharmaceuticals, Inc. (formerly known as Arrowhead Research Corp.) He is a Member of the National Academy of Engineering, the Institute of Medicine and National Academy of Science. He is a member of the Experimental Therapeutics Program at the City of Hope Cancer Center and the Jonsson Comprehensive Cancer Center at UCLA. His research focuses on creating polymers for the delivery of a broad range of therapeutics, including siRNA. He is the Warren and Katharine Schlinger Professor of Chemical Engineering of California Institute of Technology. He is a Professor of Microbiology and Immunology of Stanford University and an Investigator with the Howard Hughes Medical Institute. Dr. Davis received a BA from Johns Hopkins University and a PhD from the California Institute of Technology.

Positions